{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T11:28:46Z","timestamp":1781522926499,"version":"3.54.1"},"reference-count":56,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002383","name":"King Saud University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002383","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cardiology Clinics"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.ccl.2021.04.013","type":"journal-article","created":{"date-parts":[[2021,7,8]],"date-time":"2021-07-08T22:14:03Z","timestamp":1625782443000},"page":"447-453","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["A Comparison of Hemodialysis and Peritoneal Dialysis in Patients with Cardiovascular Disease"],"prefix":"10.1016","volume":"39","author":[{"given":"Rehab B.","family":"Albakr","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanne M.","family":"Bargman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ccl.2021.04.013_bib1","doi-asserted-by":"crossref","first-page":"A6","DOI":"10.1053\/j.ajkd.2019.09.003","article-title":"US renal data system 2019 annual data report: epidemiology of kidney disease in the United States","volume":"75","author":"Saran","year":"2020","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.ccl.2021.04.013_bib2","first-page":"S16","article-title":"Epidemiology of cardiovascular disease in chronic renal disease","volume":"9","author":"Foley","year":"1998","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.ccl.2021.04.013_bib3","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0002-9343(03)00366-8","article-title":"Prevalence, treatment, and control of hypertension in chronic hemodialysis patients in the United States","volume":"115","author":"Agarwal","year":"2003","journal-title":"Am J Med"},{"key":"10.1016\/j.ccl.2021.04.013_bib4","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0272-6386(00)70335-0","article-title":"Interdialytic weight gain, compliance with dialysis regimen, and age are independent predictors of blood pressure in hemodialysis patients","volume":"35","author":"Rahman","year":"2000","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.ccl.2021.04.013_bib5","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1159\/000331067","article-title":"Epidemiology of interdialytic ambulatory hypertension and the role of volume excess","volume":"34","author":"Agarwal","year":"2011","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.ccl.2021.04.013_bib6","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1097\/HJH.0000000000001283","article-title":"Hypertension in dialysis patients","volume":"35","author":"Sarafidis","year":"2017","journal-title":"J\u00a0Hypertens"},{"key":"10.1016\/j.ccl.2021.04.013_bib7","first-page":"211","article-title":"Blood pressure and mortality in long-term hemodialysis-time to move forward","volume":"30","author":"Georgianos","year":"2017","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.ccl.2021.04.013_bib8","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.jash.2011.02.004","article-title":"Hypertension in peritoneal dialysis patients: epidemiology, pathogenesis, and treatment","volume":"5","author":"Ortega","year":"2011","journal-title":"J\u00a0Am Soc Hypertens"},{"key":"10.1016\/j.ccl.2021.04.013_bib9","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.1681\/ASN.V12102158","article-title":"Relative contribution of residual renal function and peritoneal clearance to adequacy of dialysis: a reanalysis of the CANUSA study","volume":"12","author":"Bargman","year":"2001","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.ccl.2021.04.013_bib10","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1038\/ajh.2008.286","article-title":"Association between pulse pressure and 30-month all-cause mortality in peritoneal dialysis patients","volume":"21","author":"Liu","year":"2008","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.ccl.2021.04.013_bib11","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/S0272-6386(99)70413-0","article-title":"Mechanism of erythropoietin-induced hypertension","volume":"33","author":"Vaziri","year":"1999","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.ccl.2021.04.013_bib12","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1681\/ASN.2013060601","article-title":"Assessment and management of hypertension in patients on dialysis","volume":"25","author":"Agarwal","year":"2014","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.ccl.2021.04.013_bib13","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/ki.2009.469","article-title":"Blood pressure in chronic kidney disease stage 5D\u2014report from a Kidney Disease: Improving Global Outcomes controversies conference","volume":"77","author":"Levin","year":"2010","journal-title":"Kidney Int"},{"key":"10.1016\/j.ccl.2021.04.013_bib14","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/kisup.2011.1","article-title":"The lingering dilemma of arterial pressure in CKD: what do we know, where do we go?","volume":"1","author":"Agarwal","year":"2011","journal-title":"Kidney Int Suppl"},{"key":"10.1016\/j.ccl.2021.04.013_bib15","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1053\/ajkd.2001.22085","article-title":"Strict volume control normalizes hypertension in peritoneal dialysis patients","volume":"37","author":"G\u00fcnal","year":"2001","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.ccl.2021.04.013_bib16","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1186\/1471-2369-14-249","article-title":"Patterns in blood pressure medication use in US incident dialysis patients over the first 6 months","volume":"14","author":"St Peter","year":"2013","journal-title":"BMC Nephrol"},{"key":"10.1016\/j.ccl.2021.04.013_bib17","doi-asserted-by":"crossref","first-page":"105","DOI":"10.7326\/0003-4819-139-2-200307150-00010","article-title":"Effects of an angiotensin-converting enzyme inhibitor on residual renal function in patients receiving peritoneal dialysis: a randomized, controlled study","volume":"139","author":"Li","year":"2003","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ccl.2021.04.013_bib18","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1053\/j.ajkd.2004.01.019","article-title":"Effects of an angiotensin II receptor blocker, valsartan, on residual renal function in patients on CAPD","volume":"43","author":"Suzuki","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.ccl.2021.04.013_bib19","doi-asserted-by":"crossref","first-page":"114","DOI":"10.3747\/pdi.2011.00332","article-title":"Pharmacologic targets and peritoneal membrane remodeling","volume":"34","author":"Farhat","year":"2014","journal-title":"Perit Dial Int"},{"key":"10.1016\/j.ccl.2021.04.013_bib20","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1093\/ndt\/gfn421","article-title":"A\u00a0positive effect of AII inhibitors on peritoneal membrane function in long-term PD patients","volume":"24","author":"Kolesnyk","year":"2009","journal-title":"Nephrol Dial Transplant"},{"issue":"5","key":"10.1016\/j.ccl.2021.04.013_bib21","first-page":"862","article-title":"Angiotensin-converting enzyme inhibitor\/angiotensin receptor blocker use and cardiovascular outcomes in patients initiating peritoneal dialysis","volume":"32","author":"Shen","year":"2016","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.ccl.2021.04.013_bib22","doi-asserted-by":"crossref","first-page":"3704","DOI":"10.1093\/ndt\/gfn321","article-title":"Use of ACE inhibitors or angiotensin receptor blockers and survival in patients on peritoneal dialysis","volume":"23","author":"Fang","year":"2008","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.ccl.2021.04.013_bib23","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1053\/ajkd.2002.36340","article-title":"ACE inhibitors and survival of hemodialysis patients","volume":"40","author":"Efrati","year":"2002","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.ccl.2021.04.013_bib24","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1038\/jhh.2015.119","article-title":"Effects of mineralocorticoid receptor antagonists in patients with hypertension and diabetes mellitus: a systematic review and meta-analysis","volume":"30","author":"Takahashi","year":"2016","journal-title":"J\u00a0Hum Hypertens"},{"key":"10.1016\/j.ccl.2021.04.013_bib25","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jchf.2018.10.017","article-title":"Efficacy and safety of spironolactone in patients with HFpEF and chronic kidney disease","volume":"7","author":"Beldhuis","year":"2019","journal-title":"JACC Hear Fail"},{"key":"10.1016\/j.ccl.2021.04.013_bib26","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.jacc.2013.09.056","article-title":"Spironolactone reduces cardiovascular and cerebrovascular morbidity and mortality in hemodialysis patients","volume":"63","author":"Matsumoto","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.ccl.2021.04.013_bib27","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/jch.12628","article-title":"Long-term effects of low-dose spironolactone on chronic dialysis patients: a randomized placebo-controlled study","volume":"18","author":"Lin","year":"2016","journal-title":"J\u00a0Clin Hypertens"},{"key":"10.1016\/j.ccl.2021.04.013_bib28","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.kint.2019.02.030","article-title":"Mineralocorticoid receptor antagonists and kidney diseases: pathophysiological basis","volume":"96","author":"Barrera-Chimal","year":"2019","journal-title":"Kidney Int"},{"key":"10.1016\/j.ccl.2021.04.013_bib29","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/j.kint.2018.11.025","article-title":"A\u00a0randomized controlled trial of the effect of spironolactone on left ventricular mass in hemodialysis patients","volume":"95","author":"Hammer","year":"2019","journal-title":"Kidney Int"},{"key":"10.1016\/j.ccl.2021.04.013_bib30","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.3390\/ijms18081682","article-title":"Sympathetic overactivity in chronic kidney disease: consequences and mechanisms","volume":"18","author":"Kaur","year":"2017","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ccl.2021.04.013_bib31","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.2215\/CJN.10010911","article-title":"Probing the mechanisms of intradialytic hypertension: a pilot study targeting endothelial cell dysfunction","volume":"7","author":"Inrig","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.ccl.2021.04.013_bib32","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1681\/ASN.2014040324","article-title":"\u03b2 -blocker dialyzability and mortality in older patients receiving hemodialysis","volume":"26","author":"Weir","year":"2015","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.ccl.2021.04.013_bib33","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1159\/000496083","article-title":"Effects of beta-blockers on cardiovascular events and mortality in dialysis patients: a systematic review and meta-analysis","volume":"48","author":"Jin","year":"2019","journal-title":"Blood Purif"},{"key":"10.1016\/j.ccl.2021.04.013_bib34","doi-asserted-by":"crossref","first-page":"3605","DOI":"10.1093\/ndt\/gfn304","article-title":"Effect of amlodipine on cardiovascular events in hypertensive haemodialysis patients","volume":"23","author":"Tepel","year":"2008","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.ccl.2021.04.013_bib35","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1046\/j.1523-1755.2001.0590031128.x","article-title":"Role of diuretics in the preservation of residual renal function in patients on continuous ambulatory peritoneal dialysis","volume":"59","author":"Medcalf","year":"2001","journal-title":"Kidney Int"},{"key":"10.1016\/j.ccl.2021.04.013_bib36","doi-asserted-by":"crossref","first-page":"95","DOI":"10.2215\/CJN.05080418","article-title":"Association of continuation of loop diuretics at hemodialysis initiation with clinical outcomes","volume":"14","author":"Sibbel","year":"2019","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.ccl.2021.04.013_bib37","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1159\/000245634","article-title":"Haemodialysis-induced myocardial stunning in chronic kidney disease: a new aspect of cardiovascular disease","volume":"29","author":"McIntyre","year":"2010","journal-title":"Blood Purif"},{"key":"10.1016\/j.ccl.2021.04.013_bib38","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1681\/ASN.2016060686","article-title":"Intradialytic cardiac magnetic resonance imaging to assess cardiovascular responses in a short-term trial of hemodiafiltration and hemodialysis","volume":"28","author":"Buchanan","year":"2017","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.ccl.2021.04.013_bib39","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1681\/ASN.2017101088","article-title":"Hemodialysis induces an acute decline in cerebral blood flow in elderly patients","volume":"29","author":"Polinder-Bos","year":"2018","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.ccl.2021.04.013_bib40","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3747\/pdi.2010.00007","article-title":"Peritoneal dialysis is not associated with myocardial stunning","volume":"31","author":"Selby","year":"2011","journal-title":"Perit Dial Int J Int Soc Perit Dial"},{"key":"10.1016\/j.ccl.2021.04.013_bib41","doi-asserted-by":"crossref","first-page":"914","DOI":"10.2215\/CJN.03900808","article-title":"Hemodialysis-induced cardiac injury: determinants and associated outcomes","volume":"4","author":"Burton","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.ccl.2021.04.013_bib42","first-page":"227","article-title":"Predictive factors for coronary artery disease among peritoneal dialysis patients without diabetic nephropathy","volume":"7","author":"Andronesi","year":"2012","journal-title":"Maedica (Buchar)"},{"key":"10.1016\/j.ccl.2021.04.013_bib43","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/1744-9987.12676","article-title":"Association between dialysis modalities and risk of coronary artery disease: a population-based cohort study in Taiwan","volume":"22","author":"Hung","year":"2018","journal-title":"Ther Apher Dial"},{"key":"10.1016\/j.ccl.2021.04.013_bib44","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1093\/ckj\/sfx124","article-title":"Is progression of coronary artery calcification influenced by modality of renal replacement therapy? A systematic review","volume":"11","author":"Jansz","year":"2018","journal-title":"Clin Kidney J"},{"key":"10.1016\/j.ccl.2021.04.013_bib45","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.2215\/CJN.02760218","article-title":"Mapping progress in reducing cardiovascular risk with kidney disease","volume":"13","author":"Shafi","year":"2018","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.ccl.2021.04.013_bib46","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.ahj.2016.07.004","article-title":"Kidney function and sudden cardiac death in the community: the Atherosclerosis Risk in Communities (ARIC) Study","volume":"180","author":"Suzuki","year":"2016","journal-title":"Am Heart J"},{"key":"10.1016\/j.ccl.2021.04.013_bib47","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1056\/NEJMoa1103313","article-title":"Long interdialytic interval and mortality among patients receiving hemodialysis","volume":"365","author":"Foley","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ccl.2021.04.013_bib48","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1016\/j.hrthm.2015.06.033","article-title":"Temporal distribution of arrhythmic events in chronic kidney disease: highest incidence in the long interdialytic period","volume":"12","author":"Wong","year":"2015","journal-title":"Hear Rhythm"},{"key":"10.1016\/j.ccl.2021.04.013_bib49","first-page":"493","article-title":"Predictors of arrhythmic events detected by implantable loop recorders in renal transplant candidates","volume":"105","author":"Silva","year":"2015","journal-title":"Arq Bras Cardiol"},{"key":"10.1016\/j.ccl.2021.04.013_bib50","doi-asserted-by":"crossref","first-page":"e0188713","DOI":"10.1371\/journal.pone.0188713","article-title":"Monitoring of arrhythmia and sudden death in a hemodialysis population: the CRASH-ILR Study","volume":"12","author":"Roberts","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.ccl.2021.04.013_bib51","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1053\/j.ajkd.2018.09.011","article-title":"Dialysis modality and incident atrial fibrillation in older patients with ESRD","volume":"73","author":"Niu","year":"2019","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.ccl.2021.04.013_bib52","doi-asserted-by":"crossref","first-page":"805","DOI":"10.2215\/CJN.06810619","article-title":"Intradialytic hypotension and cardiac arrhythmias in patients undergoing maintenance hemodialysis","volume":"15","author":"Mc Causland","year":"2020","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.ccl.2021.04.013_bib53","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1093\/ndt\/gfp484","article-title":"Efficacy of peritoneal ultrafiltration in the treatment of refractory congestive heart failure","volume":"25","author":"Sanchez","year":"2010","journal-title":"Nephrol Dial Transpl"},{"key":"10.1016\/j.ccl.2021.04.013_bib54","doi-asserted-by":"crossref","first-page":"2794","DOI":"10.1093\/ndt\/gfr756","article-title":"Prospective study on clinical effects of renal replacement therapy in treatment-resistant congestive heart failure","volume":"27","author":"Cnossen","year":"2012","journal-title":"Nephrol Dial Transpl"},{"key":"10.1016\/j.ccl.2021.04.013_bib55","doi-asserted-by":"crossref","first-page":"386","DOI":"10.3747\/pdi.2011.00076","article-title":"Renal replacement therapy in congestive heart failure requiring left ventricular assist device augmentation","volume":"32","author":"Thomas","year":"2012","journal-title":"Perit Dial Int J Int Soc Perit Dial"},{"key":"10.1016\/j.ccl.2021.04.013_bib56","article-title":"A\u00a0single-center retrospective study on the initiation of peritoneal dialysis in patients with cardiorenal syndrome and subsequent hospitalizations","volume":"7","author":"Auguste","year":"2020","journal-title":"Can J Kidney Heal Dis"}],"container-title":["Cardiology Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733865121000369?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733865121000369?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T10:54:58Z","timestamp":1760007298000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0733865121000369"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":56,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["S0733865121000369"],"URL":"https:\/\/doi.org\/10.1016\/j.ccl.2021.04.013","relation":{},"ISSN":["0733-8651"],"issn-type":[{"value":"0733-8651","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Comparison of Hemodialysis and Peritoneal Dialysis in Patients with Cardiovascular Disease","name":"articletitle","label":"Article Title"},{"value":"Cardiology Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ccl.2021.04.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}